Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

News Releases

  •   Email
  •   Print
  •   Share

  • Some patients with a form of advanced kidney cancer benefited from an experimental drug targeted to an abnormal genetic pathway causing cancerous growth, according to research led by Dana-Farber scientists.

Tags: chemotherapy, BasicResearch

  • New study shows CDK4/6-inhibiting drug palbociclib not only arrests cancer cell division but can also induce cancer cell death in tumors with high level of key protein. Discovery raises prospect of clinical test to identify patients who can gain particular benefit from CDK4/6 inhibitors.

Tags: TargetedTherapy

  • Dana-Farber researcher Gordon Freeman, PhD, is one of five scientists to be awarded the 2017 Warren Alpert Foundation Prize for transformative discoveries in the field of cancer immunology.

Tags: Honors, Immunotherapy

  • The National Cancer Institute has awarded four Dana-Farber Cancer Institute researchers with Outstanding Investigator Awards for ongoing progressive research within their respective areas of study.

Tags: BasicResearch, Grants

  • Eric Winer, MD, was recognized by ASCO for his distinguished record of accomplishments in advancing the field of breast cancer.

Tags: BreastCancer, Honors

  • Lesley Solomon has been named to the newly-created position of senior vice president for innovation and chief innovation officer at Dana-Farber Cancer Institute.

Tags: Appointments

  • New Dana-Farber study finds patients with blood cancers are less likely to receive hospice care at the end of life than patients with solid tumors.

Tags: EndOfLife

  • A multi-institutional effort led by Dana-Farber Cancer Institute researchers has shown that high doses of vitamin D may slow the progress of metastatic colorectal cancer.

Tags: ColonCancer

  • A multi-institutional study led by Dana-Farber Cancer Institute scientists has demonstrated that healthy lifestyles significantly boosted survival among patients treated with surgery and chemotherapy for stage III colon cancer.

Tags: ColonCancer

  • A new genomic study has identified prostate cancer mutations that may be more common in men of African-American background and which might be a step toward explaining why the disease is more prevalent and deadly in that minority group, says a report from Dana-Farber Cancer Institute.

Tags: Genomics, ProstateCancer, Genetics

Showing 1-10 of 788 items